Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of skin and bronchial sensitization following short-intensive scheduled immunotherapy in mite-allergic

P García-Ortega1, A Merelo, J Marrugat

  • 1Department of Medicine, Hospital Joan XXIII, Universidad de Barcelona (División VII), Tarragona, Spain.

Chest
|January 1, 1993
PubMed
Summary

High-dose intensive specific immunotherapy (ISI) significantly reduced mite sensitization and allergic responses in asthma patients. However, clinical symptoms did not improve, likely due to unchanged nonspecific hyperreactivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased risk of arrhythmias, heart failure, and thrombosis in SARS-CoV-2 positive individuals persists at one year post-infection.

Computational and structural biotechnology journal·2024
Same author

Genomic diversity and signals of selection processes in wild and farm-reared red-legged partridges (Alectoris rufa).

Genomics·2023
Same author

Erratum to "Second Consensus on Treatment of Patients Recently Diagnosed with Mild Hypertension and Low Cardiovascular Risk". [YMCD 45/10 (October 2020) 100653].

Current problems in cardiology·2021
Same author

A cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in six European countries.

European journal of preventive cardiology·2021
Same author

Corrigendum: Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study.

Human molecular genetics·2018
Same author

Prevalence and incidence of hyperkalaemia in the Spanish population with heart failure with reduced ejection fraction: a systematic review and populational relevance.

Revista clinica espanola·2018

Area of Science:

  • Immunology
  • Allergy Research
  • Respiratory Medicine

Background:

  • Mite-allergic bronchial asthma affects numerous individuals globally.
  • Current treatments often manage symptoms rather than addressing underlying sensitization.
  • Intensive specific immunotherapy (ISI) offers a potential therapeutic avenue.

Purpose of the Study:

  • To evaluate the effects of high-dose intensive specific immunotherapy (ISI) using Dermatophagoides pteronyssinus extract.
  • To assess changes in both specific and nonspecific allergic responses in patients with mite-allergic asthma.
  • To correlate immunological changes with clinical outcomes after ISI.

Main Methods:

  • A study involving 18 patients with mite-allergic asthma undergoing ISI and 18 control patients.

Related Experiment Videos

  • Utilized a biologically standardized Dermatophagoides pteronyssinus extract for in vivo testing and immunotherapy.
  • Measured immediate and delayed skin test responses, bronchial tolerance, and specific antibody levels (IgG, IgG4, IgE).

    • Main Results:

    • ISI significantly reduced immediate (20-fold) and delayed mite skin test responses.
    • Bronchial tolerance to Dermatophagoides pteronyssinus increased tenfold in the ISI group.
    • Specific IgG and IgG4 levels increased significantly, while IgE and other IgG subclasses remained unchanged.
    • Nonspecific bronchial hyperreactivity was not affected by ISI.
    • Clinical scores showed no significant improvement post-ISI.

    Conclusions:

    • Short-term, high-dose ISI with a standardized mite extract effectively reduces mite sensitization and allergic responses.
    • The lack of clinical improvement suggests that nonspecific hyperreactivity plays a crucial role in persistent asthma symptoms.
    • Further research is needed to address nonspecific hyperreactivity in conjunction with immunotherapy for better clinical outcomes.